Sila Realty Trust, Inc. (NYSE: SILA) (“Sila”, the “Company”, “we”, or “us”), a net lease real estate investment trust (“REIT”) with a strategic focus on investing in the growing and resilient healthcare sector, today announced operating results for the fourth quarter and year ended December 31, 2025.

Highlights for the quarter ended December 31, 2025:

Highlights for the year ended December 31, 2025:

Subsequent Events

Management Commentary

"The Sila team's prowess in allocating capital was on full display in 2025," stated Michael A. Seton, President and Chief Executive Officer of the Company. "We successfully acquired six high quality healthcare properties for approximately $149 million, all of which play a critical role in the social infrastructure of their respective patient communities.

"Our portfolio's performance in 2025 demonstrates the strength of Sila's proactive asset management capabilities, evidenced by successful rent collections, high tenant lease renewal rates, and new capital allocations for existing property expansions that have clear tenant operational needs. Our high EBITDARM rent coverage ratios and a long weighted average remaining lease term of 10-years provide us with continued confidence in the strength, sustainability, and predictability of our income streams.

"As we look forward to 2026 and beyond, our liquidity of almost $500 million and low net debt* to annualized EBITDAre* ratio of 3.9x, position Sila to take advantage of high quality opportunities as they may arise, while remaining thoughtful and disciplined in our approach to investing in necessity based healthcare real estate."

*Some of the financial measures throughout this press release are non-GAAP measures. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and reconciliations to the most directly comparable GAAP measure.

Financial Results

Net Income

Our GAAP net income for the fourth quarter of 2025 was $5.0 million, or $0.09 per diluted share, compared to $11.1 million, or $0.20 per diluted share, for the fourth quarter of 2024. Our GAAP net income for the year ended December 31, 2025 was $33.1 million, or $0.60 per diluted share, compared to $42.7 million, or $0.75 per diluted share for the year ended December 31, 2024.

Cash NOI

Cash NOI was $44.0 million for the fourth quarter of 2025, as compared to $41.0 million for the fourth quarter of 2024. The increase in Cash NOI is primarily the result of acquisitions and same-store Cash NOI growth of 0.7%.

Cash NOI was $169.9 million for the year ended December 31, 2025, as compared to $168.6 million for the year ended December 31, 2024. The increase in Cash NOI is primarily due to acquisitions and same-store Cash NOI growth of 0.9%. The increase was partially offset by the receipt of a lease termination fee and the severance fee received from GenesisCare USA, Inc. and its affiliates in the first quarter of 2024, the Stoughton Healthcare Facility as a result of the Steward Health Care System LLC, or Steward, bankruptcy, and property dispositions.

AFFO

AFFO was $30.4 million, or $0.55 per diluted share, during the fourth quarter of 2025, compared to $30.2 million, or $0.54 per diluted share, during the fourth quarter of 2024.

AFFO for the year ended December 31, 2025 was $120.9 million, or $2.18 per diluted share, compared to $131.1 million, or $2.31 per diluted share, for the year ended December 31, 2024.

Real Estate Portfolio Highlights

Investment Activity

During the quarter ended December 31, 2025, the Company placed in service two properties that underwent redevelopments during the year. One was the renovation of a 44,746 rentable square foot inpatient rehabilitation facility in San Antonio, Texas, and the other was a renovation of a 12,163 rentable square foot medical outpatient building in El Segundo, California.

Portfolio

As of December 31, 2025, Sila's well diversified real estate portfolio consisted of 140 properties comprising approximately 5.3 million rentable square feet. The weighted average remaining lease term was 10.0 years with 22.1% of annualized base rent maturing in the next five years and a weighted average fixed rent escalation rate of 2.1%, excluding leases tied to the consumer price index.

As of December 31, 2025, the percentage of rentable square feet leased was 98.7%. There was a 0.4 percentage point decrease in the percentage of square feet leased when compared to the third quarter of 2025, primarily attributable to the expiration of a lease consisting of 15,600 rentable square feet.

Balance Sheet and Capital Markets Activities

Sila had a strong balance sheet as of December 31, 2025, with its liquidity position totaling approximately $481.3 million, consisting of $32.3 million in cash and cash equivalents and $449.0 million of availability under its unsecured credit facilities.

Total principal debt outstanding under the unsecured credit facilities as of December 31, 2025, was $676.0 million. Of the $676.0 million, $525.0 million was fixed through 10 interest rate swap agreements. As of December 31, 2025, the Company's weighted average interest rate on the total principal debt outstanding was 4.7%, including the impact of the interest rate swap agreements. As of December 31, 2025, net debt to enterprise value was approximately 33.3%.

Distributions

The Company's dividend payout to AFFO ratio was 72.6% for the quarter ended December 31, 2025. On February 23, 2026, the Board approved and authorized a quarterly cash dividend of $0.40 per share of common stock payable on March 18, 2026, to the Company's stockholders of record as of the close of business on March 6, 2026. The quarterly cash dividend of $0.40 per share represents an annualized amount of $1.60 per share.

Conference Call and Webcast

A conference call and audio webcast for investors and analysts will be held on Wednesday, February 25, 2026, at 11:00 a.m. Eastern Time to discuss our fourth quarter and year ended 2025 operating results and to answer questions. The live and archived webcast can be accessed on the "Events" page of the Company's website atinvestors.silarealtytrust.com https://events.q4inc.com/attendee/316667282

About Sila Realty Trust, Inc.

Sila Realty Trust, Inc., headquartered in Tampa, Florida, is a net lease real estate investment trust with a strategic focus on investing in the growing and resilient healthcare sector. The Company invests in high quality healthcare facilities along the continuum of care in the pursuit of generating predictable, durable, and growing income streams. Sila's portfolio comprises high quality tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients. As of December 31, 2025, the Company owned 140 real estate properties and three undeveloped land parcels, including the Stoughton Healthcare Facility which has been taken out of service and is being demolished, located in 67 markets across the United States. For more information, please visit the Company's website atwww.silarealtytrust.com

Forward-Looking Statements

Certain statements contained herein, other than historical fact, may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provided by the same. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties. No forward-looking statement is intended to, nor shall it, serve as a guarantee of future performance. You can identify the forward-looking statements by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “seek,” “endeavor,” “should,” “will” and other similar terms and phrases, including statements about and references to,www.sec.gov

Supplemental Information

The Company routinely provides information for investors and the marketplace through press releases, SEC filings, public conference calls, and the Company's website atinvestors.silarealtytrust.com

Consolidated Balance Sheets (amounts in thousands, except share data and per share amounts)

Consolidated Quarterly and Annual Statements of Comprehensive Income (amounts in thousands, except share data and per share amounts) (unaudited)

Non-GAAP Financial Measures

This press release includes certain financial performance measures not defined by United States generally accepted accounting principles, or GAAP. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in this press release. In the real estate industry, analysts and investors employ certain non-GAAP supplemental financial measures in order to facilitate meaningful comparisons between periods and among peer companies. We believe that the non-GAAP financial measures we disclose are useful to investors to consider because they may assist them to better understand and measure the performance of our business over time and against similar companies. We use the following non-GAAP financial measures: Funds From Operations, or FFO, Core Funds From Operations, or Core FFO, AFFO, Cash NOI, Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, EBITDA for Real Estate, or EBITDAre, Net Debt, as well as ratios derived from the foregoing. Our definitions and calculations of these non-GAAP financial measures may not be the same as similar measures reported by other REITs.

A description of FFO, Core FFO, AFFO, EBITDA and EBITDAre, and reconciliations of these non-GAAP measures to net income, the most directly comparable GAAP measure, a description of same store cash NOI and reconciliation of this non-GAAP measure to rental revenue, the most directly comparable GAAP measure, and a description of net debt and reconciliation of this non-GAAP measure to total credit facility, net, the most directly comparable GAAP measure, are provided below.

These non-GAAP financial measures should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of our financial performance, as alternatives to cash flows from operating activities (determined in accordance with GAAP), or as measures of our liquidity, nor are these measures necessarily indicative of sufficient cash flows to fund all of our needs.

Reconciliation of Net Income to FFO, Core FFO and AFFO (amounts in thousands)

FFO

FFO is calculated consistent with the National Association of Real Estate Investment Trusts, or Nareit's, definition, as net income (calculated in accordance with GAAP), excluding gains and losses from sales of real estate assets, impairment of real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity, and depreciation and amortization of real estate assets. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. We do not have any investments in unconsolidated partnerships or joint ventures. We believe FFO provides a useful understanding of our performance to investors and to our management, and when compared to year over year, FFO reflects the impact on our operations from trends in occupancy. It should be noted, however, that other REITs may not define FFO in accordance with the current Nareit definition or may interpret the current Nareit definition differently than the Company does, making comparisons less meaningful.

Core FFO

The Company believes Core FFO is a supplemental financial performance measure that provides investors with additional information to understand the Company's sustainable performance. The Company calculates Core FFO by adjusting FFO to remove the effect of certain GAAP non-cash income and expense items, unusual and infrequent items that are not expected to impact its operating performance on an ongoing basis, items that affect comparability to prior periods and/or items that are not related to its core real estate operations. Excluded items include listing-related expenses, severance, write-off of straight-line rent receivables related to prior periods, accelerated stock-based compensation, amortization of above- and below-market lease intangibles (including ground leases), loss on extinguishment of debt, changes in the current expected credit loss reserve and demolition costs. Other REITs may use different methodologies for calculating Core FFO and, accordingly, the Company’s Core FFO may not be comparable to other REITs.

AFFO

The Company believes AFFO is a supplemental financial performance measure that provides investors appropriate supplemental information to evaluate the ongoing operations of the Company. AFFO is a metric used by management to evaluate the Company's dividend policy. The Company calculates AFFO by further adjusting Core FFO for the following items: deferred rent, current period straight-line rent adjustments, amortization of deferred financing costs, amortization of fees on our real estate related notes receivable, and stock-based compensation. Other REITs may use different methodologies for calculating AFFO and, accordingly, the Company’s AFFO may not be comparable to other REITs.

FFO, Core FFO and AFFO should not be considered to be more relevant or accurate than the GAAP methodology in calculating net income or in its applicability in evaluating the Company's operational performance. The method used to evaluate the value and performance of real estate under GAAP should be considered a more relevant measure of operating performance and more prominent than the non-GAAP FFO, Core FFO and AFFO measures and the adjustments to GAAP in calculating FFO, Core FFO and AFFO.

Reconciliation of Net Income to Same Store Cash Net Operating Income (Same Store Cash NOI) (amounts in thousands)

NOI

The Company defines net operating income or loss, or NOI, a non-GAAP financial measure, as rental revenue, less rental expenses, on an accrual basis.

Same Store Properties

In order to evaluate the overall portfolio, management analyzes the NOI of same store properties. The Company defines "same store properties" as properties that were owned and operated for the entirety of both calendar periods being compared and excludes properties under development, re-development, or classified as held for sale. By evaluating same store properties, management is able to monitor the operations of the Company's existing properties for comparable periods to measure the performance of the current portfolio and readily observe the expected effects of new acquisitions and dispositions on net income. There were 132 same store properties for the quarters ended December 31, 2025 and 2024. There were 124 same store properties for the years ended December 31, 2025 and 2024.

Cash NOI

The Company defines Cash NOI as NOI for its properties excluding the impact of GAAP adjustments to rental revenue and rental expenses, consisting of straight-line rent adjustments, net of write-offs, amortization of above- and below-market lease intangibles (including ground leases) and internal property management fees, then including deferred rent received in cash. Cash NOI is used to evaluate the cash-based performance of the Company’s real estate portfolio. Same store Cash NOI is calculated to exclude non-same store Cash NOI. The Company believes that NOI and Cash NOI both serve as useful supplements to net income because they allow investors and management to measure unlevered property-level operating results and to compare these results to the comparable results of other real estate companies on a consistent basis. Other real estate companies may use different methodologies for calculating Cash NOI and, accordingly, the Company’s Cash NOI may not be comparable to other real estate companies. The Company uses both NOI and Cash NOI to make decisions about resource allocations and to assess the property-level performance of the real estate portfolio.

Reconciliation of Net Income to EBITDA and EBITDAre (amounts in thousands)

EBITDA and EBITDAre

EBITDA and EBITDAre are defined as net income or loss, calculated in accordance with GAAP, adjusted for interest expense, income tax expense (benefit), depreciation and amortization. EBITDAre also includes adjustments for impairments of real estate assets, losses from the disposition of properties, and gains from the disposition of properties. EBITDAre is a definition promulgated by Nareit. The Company believes these metrics are important indicators of the Company’s operating performance and its ability to service debt.

The Company calculates annualized EBITDAre by taking the current month amount, removing lease termination income and items that are not a result of normal operations, and multiplying by twelve months.

Reconciliation of the Company's Total Unsecured Credit Facilities Debt, Net to Net Debt (amounts in thousands)

Net Debt

The Company defines net debt as principal debt outstanding less cash and cash equivalents. Net debt provides useful information by calculating and monitoring the Company’s leverage metrics.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260224524593/en/


	(Unaudited)
	December 31, 2025			December 31, 2024
ASSETS
Real estate:
Land	$	171,848		$	160,743
Buildings and improvements, less accumulated depreciation of $331,437 and $277,024, respectively		1,616,905			1,546,877
Total real estate, net		1,788,753			1,707,620
Cash and cash equivalents		32,288			39,844
Real estate related notes receivable, net of current expected credit loss reserve of $180 and $0, respectively		17,106			—
Intangible assets, less accumulated amortization of $112,292 and $122,208, respectively		116,693			125,655
Goodwill		17,635			17,700
Right-of-use assets - operating leases		35,008			36,332
Right-of-use assets - finance lease		1,901			—
Other assets		85,119			79,923
Total assets	$	2,094,503		$	2,007,074
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities:
Credit facility, net of deferred financing costs of $1,878 and $3,079, respectively	$	674,122		$	521,921
Accounts payable and other liabilities		42,183			33,405
Intangible liabilities, less accumulated amortization of $8,939 and $8,761, respectively		5,810			7,070
Operating lease liabilities		41,013			41,493
Finance lease liabilities		77			—
Total liabilities		763,205			603,889
Stockholders’ equity:
Preferred stock, $0.01 par value per share, 100,000,000 shares authorized; none issued and outstanding		—			—
Common stock, $0.01 par value per share, 510,000,000 shares authorized; 61,939,043 and 61,779,631 shares issued, respectively; 54,876,558 and 55,075,006 shares outstanding, respectively		549			551
Additional paid-in capital		1,994,960			1,998,777
Distributions in excess of accumulated earnings		(663,197	)		(607,499	)
Accumulated other comprehensive (loss) income		(1,014	)		11,356
Total stockholders’ equity		1,331,298			1,403,185
Total liabilities and stockholders’ equity	$	2,094,503		$	2,007,074

	Three Months Ended December 31,						Year Ended December 31,
	2025			2024			2025			2024
Revenue:
Rental revenue	$	50,083		$	46,545		$	196,304		$	186,856
Real estate related notes receivable interest income		617			—			1,232			—
Total revenues		50,700			46,545			197,536			186,856
Expenses:
Rental expenses		5,567			5,912			23,804			23,138
Listing-related expenses		—			—			—			3,012
General and administrative expenses		5,539			7,015			20,907			25,336
Depreciation and amortization		21,606			17,745			76,946			74,754
Impairment and disposition losses		3,159			—			9,951			1,210
Demolition costs		864			—			1,011			—
Total operating expenses		36,735			30,672			132,619			127,450
Other income (expense):
Gain on dispositions of real estate		—			265			—			341
Interest and other income		212			241			1,169			4,130
Interest expense		(9,162	)		(5,265	)		(32,786	)		(21,220	)
Increase in current expected credit loss reserve		—			—			(180	)		—
Total other expense		(8,950	)		(4,759	)		(31,797	)		(16,749	)
Net income attributable to common stockholders	$	5,015		$	11,114		$	33,120		$	42,657
Other comprehensive (loss) income - unrealized (loss) gain on interest rate swaps, net		(301	)		5,370			(12,370	)		(5,247	)
Comprehensive income attributable to common stockholders	$	4,714		$	16,484		$	20,750		$	37,410
Weighted average number of common shares outstanding:
Basic		54,876,558			55,019,874			55,005,993			56,228,545
Diluted		55,322,140			55,510,399			55,514,984			56,685,496
Net income per common share attributable to common stockholders:
Basic	$	0.09		$	0.20		$	0.60		$	0.75
Diluted	$	0.09		$	0.20		$	0.60		$	0.75

	Three Months Ended December 31,						Year Ended December 31,
	2025			2024			2025			2024
Net income attributable to common stockholders⁽¹⁾⁽²⁾	$	5,015		$	11,114		$	33,120		$	42,657
Adjustments:
Depreciation and amortization of real estate assets		21,579			17,722			76,838			74,660
Gain on dispositions of real estate		—			(265	)		—			(341	)
Impairment and disposition losses		3,159			—			9,951			1,210
FFO⁽¹⁾⁽²⁾	$	29,753		$	28,571		$	119,909		$	118,186
Adjustments:
Listing-related expenses		—			—			—			3,012
Severance		—			19			33			1,885
Write-off of straight-line rent receivables related to prior periods		426			—			462			—
Accelerated stock-based compensation		—			61			19			936
Amortization of above (below) market lease intangibles, including ground leases, net		15			347			78			1,778
Loss on extinguishment of debt		—			—			233			228
Increase in current expected credit loss reserve		—			—			180			—
Demolition costs		864			—			1,011			—
Core FFO⁽¹⁾⁽²⁾	$	31,058		$	28,998		$	121,925		$	126,025
Adjustments:
Deferred rent⁽³⁾		263			456			1,226			3,510
Straight-line rent adjustments		(2,632	)		(1,788	)		(9,763	)		(5,555	)
Amortization of deferred financing costs		725			578			2,823			2,185
Amortization of fees on real estate related notes receivable		(35	)		—			(94	)		—
Stock-based compensation		1,008			1,991			4,796			4,914
AFFO⁽¹⁾⁽²⁾	$	30,387		$	30,235		$	120,913		$	131,079

(1)	The three months ended December 31, 2025 include $214,000 of lease termination fee income received. The year ended December 31, 2025 includes $295,000 of lease termination fee income received. The year ended December 31, 2024 includes $4,098,000 of lease termination fee income received.
(2)	The year ended December 31, 2025 includes $83,000 of rental revenue received as a result of bankruptcy proceedings from Steward, the sponsor and owner of the former tenant at the Stoughton Healthcare Facility.
(3)	The year ended December 31, 2024 includes a $2,000,000 severance fee received from GenesisCare, which is recognized in rental revenues over the remaining GenesisCare amended master lease term. Additionally, the years ended December 31, 2025 and 2024 include a property that was under development. This property was placed in service in December 2025 and therefore, subsequent rent received is reflected in rental revenue and the prior deferred revenue is recognized over time in straight-line rent adjustments within rental revenues.

	Three Months Ended December 31,						Year Ended December 31,
	2025			2024			2025			2024
Rental revenue^(1)(2)(3)	$	50,083		$	46,545		$	196,304		$	186,856
Rental expenses		(5,567	)		(5,912	)		(23,804	)		(23,138	)
Net operating income		44,516			40,633			172,500			163,718
Adjustments:
Straight-line rent adjustments, net of write-offs		(2,206	)		(1,788	)		(9,301	)		(5,555	)
Amortization of above (below) market lease intangibles, including ground leases, net		15			347			78			1,778
Internal property management fee		1,375			1,312			5,357			5,139
Deferred rent⁽⁴⁾		263			456			1,226			3,510
Cash NOI^(1,2,3,4)		43,963			40,960			169,860			168,590
Non-same store cash NOI^(1,3,5)		(2,654	)		64			(16,816	)		(16,981	)
Same store cash NOI^(2,6)		41,309			41,024			153,044			151,609
Real estate related notes receivable interest income		617			—			1,232			—
Listing-related expenses		—			—			—			(3,012	)
General and administrative expenses		(5,539	)		(7,015	)		(20,907	)		(25,336	)
Depreciation and amortization		(21,606	)		(17,745	)		(76,946	)		(74,754	)
Impairment and disposition losses		(3,159	)		—			(9,951	)		(1,210	)
Demolition costs		(864	)		—			(1,011	)		—
Gain on dispositions of real estate		—			265			—			341
Interest and other income		212			241			1,169			4,130
Interest expense		(9,162	)		(5,265	)		(32,786	)		(21,220	)
Increase in current expected credit loss reserve		—			—			(180	)		—
Straight-line rent adjustments, net of write-offs		2,206			1,788			9,301			5,555
Amortization of above (below) market lease intangibles, including ground leases, net		(15	)		(347	)		(78	)		(1,778	)
Internal property management fee		(1,375	)		(1,312	)		(5,357	)		(5,139	)
Deferred rent⁽⁴⁾		(263	)		(456	)		(1,226	)		(3,510	)
Non-same store cash NOI^(1,3,5)		2,654			(64	)		16,816			16,981
Net income attributable to common stockholders^(1,2,3,4)	$	5,015		$	11,114		$	33,120		$	42,657

(1)	The year ended December 31, 2025 includes $83,000 of rental revenue received as a result of bankruptcy proceedings from Steward, the sponsor and owner of the former tenant at the Stoughton Healthcare Facility.
(2)	The three months ended December 31, 2025 include $214,000 of lease termination fee income received. The year ended December 31, 2025 includes $295,000 of lease termination fee income received.
(3)	The year ended December 31, 2024 includes $4,098,000 of lease termination fee income received.
(4)	The year ended December 31, 2024 includes a $2,000,000 severance fee received from GenesisCare, which is recognized in rental revenues over the remaining GenesisCare amended master lease term. Additionally, the years ended December 31, 2025 and 2024 include a property that was under development. This property was placed in service in December 2025 and therefore, subsequent rent received is reflected in rental revenue and the prior deferred revenue is recognized over time in straight-line rent adjustments within rental revenues.
(5)	The year ended December 31, 2024 includes $1,471,000 of the total $2,000,000 severance fee received from GenesisCare, which is recognized in rental revenues over the remaining GenesisCare amended master lease term.
(6)	The year ended December 31, 2024 includes $529,000 of the total $2,000,000 severance fee received from GenesisCare, which is recognized in rental revenues over the remaining GenesisCare amended master lease term.

	Three Months Ended December 31,					Year Ended December 31,
	2025		2024			2025		2024
Net income attributable to common stockholders	$	5,015	$	11,114		$	33,120	$	42,657
Adjustments:
Interest expense⁽¹⁾		9,162		5,265			32,786		21,220
Depreciation and amortization		21,606		17,745			76,946		74,754
EBITDA	$	35,783	$	34,124		$	142,852	$	138,631

Gain on real estate dispositions		—		(265	)		—		(341	)
Impairment and disposition losses		3,159		—			9,951		1,210
EBITDAre	$	38,942	$	33,859		$	152,803	$	139,500

(1)	Includes loss on extinguishment of debt of $233,000 and $228,000 for each of the years ended December 31, 2025 and 2024, respectively, in connection with extinguishment of our prior revolving credit agreement and the pay off of our prior term loan agreement.

	December 31, 2025		December 31, 2024
Total credit facilities debt, net	$	674,122	$	521,921
Deferred financing costs, net		1,878		3,079
Principal debt outstanding		676,000		525,000
Less: cash and cash equivalents		32,288		39,844
Net debt	$	643,712	$	485,156

Net income of $5.0 million, or $0.09 per diluted share
Cash net operating income*, or Cash NOI, of $44.0 million
Adjusted funds from operations*, or AFFO, of $30.4 million, or $0.55 per diluted share
Declared and paid cash distributions per share of $0.40 for the quarter

Net income of $33.1 million, or $0.60 per diluted share
Cash NOI of $169.9 million
AFFO of $120.9 million, or $2.18 per diluted share
Declared and paid cash distributions per share of $1.60 for the year
Acquired six operating healthcare properties, comprising approximately 241,000 rentable square feet for an aggregate purchase price of $148.9 million
Fully funded two mezzanine loans, or the Mezzanine Loans, for the development of an inpatient rehabilitation facility and a behavioral healthcare facility in Lynchburg, Virginia. The Mezzanine Loans have total loan amounts of $12.5 million and $5.0 million, respectively, and each have a maturity date of November 5, 2029

On February 23, 2026, the Board authorized a quarterly cash dividend of $0.40 per share of common stock payable on March 18, 2026, to the Company's stockholders of record as of the close of business on March 6, 2026
On January 15, 2026, the Company acquired one inpatient rehabilitation facility for $43.1 million in Oklahoma City, Oklahoma
On January 29, 2026, the Company sold the Saginaw Healthcare Facility for $14.5 million, generating net proceeds of $14.3 million, after transaction costs